BackgroundComputer-aided detection (CAD) software analyzes chest X-rays for features suggestive of tuberculosis (TB) and provides a numeric abnormality score. However, estimates of CAD accuracy for TB screening are hindered by the lack of confirmatory data among people with lower CAD scores, including those without symptoms. Additionally, the appropriate CAD score thresholds for obtaining further testing may vary according to population and client characteristics. MethodsWe screened for TB in Ugandan individuals aged [&ge;]15 years using portable chest X-rays with CAD (qXR v3). Participants were offered screening regardless of their symptoms. Those with X-ray scores above a threshold of 0.1 (range, 0 - 1) were asked to provide sputum for Xpert Ultra testing. We estimated the diagnostic accuracy of CAD for detecting Xpert-positive TB when using the same threshold for all individuals (under different assumptions about TB prevalence among people with X-ray scores <0.1), and compared this estimate to age- and/or sex-stratified approaches. FindingsOf 52,835 participants screened for TB using CAD, 8,949 (16.9%) had X-ray scores [&ge;]0.1. Of 7,219 participants with valid Xpert Ultra results, 382 (5.3%) were Xpert-positive, including 81 with trace results. Assuming 0.1% of participants with X-ray scores <0.1 would have been Xpert-positive if tested, qXR had an estimated AUC of 0.920 (95% confidence interval 0.898-0.941) for Xpert-positive TB. Stratifying CAD thresholds according to age and sex improved accuracy; for example, at 96.1% specificity, estimated sensitivity was 75.0% for a universal threshold (of [&ge;]0.65) versus 76.9% for thresholds stratified by age and sex (p=0.046). InterpretationThe accuracy of CAD for TB screening among all screening participants, including those without symptoms or abnormal chest X-rays, is higher than previously estimated. Stratifying CAD thresholds based on client characteristics such as age and sex could further improve accuracy, enabling a more effective and personalized approach to TB screening. FundingNational Institutes of Health Research in contextO_ST_ABSEvidence before this studyC_ST_ABSThe World Health Organization (WHO) has endorsed computer-aided detection (CAD) as a screening tool for tuberculosis (TB), but the appropriate CAD score that triggers further diagnostic evaluation for tuberculosis varies by population. The WHO recommends determining the appropriate CAD threshold for specific settings and population and considering unique thresholds for specific populations, including older age groups, among whom CAD may perform poorly. We performed a PubMed literature search for articles published until September 9, 2024, using the search terms "tuberculosis" AND ("computer-aided detection" OR "computer aided detection" OR "CAD" OR "computer-aided reading" OR "computer aided reading" OR "artificial intelligence"), which resulted in 704 articles. Among them, we identified studies that evaluated the performance of CAD for tuberculosis screening and additionally reviewed relevant references. Most prior studies reported area under the curves (AUC) ranging from 0.76 to 0.88 but limited their evaluations to individuals with symptoms or abnormal chest X-rays. Some prior studies identified subgroups (including older individuals and people with prior TB) among whom CAD had lower-than-average AUCs, and authors discussed how the prevalence of such characteristics could affect the optimal value of a population-wide CAD threshold; however, none estimated the accuracy that could be gained with adjusting CAD thresholds between individuals based on personal characteristics. Added value of this studyIn this study, all consenting individuals in a high-prevalence setting were offered chest X-ray screening, regardless of symptoms, if they were [&ge;]15 years old, not pregnant, and not on TB treatment. A very low CAD score cutoff (qXR v3 score of 0.1 on a 0-1 scale) was used to select individuals for confirmatory sputum molecular testing, enabling the detection of radiographically mild forms of TB and facilitating comparisons of diagnostic accuracy at different CAD thresholds. With this more expansive, symptom-neutral evaluation of CAD, we estimated an AUC of 0.920, and we found that the qXR v3 threshold needed to decrease to under 0.1 to meet the WHO target product profile goal of [&ge;]90% sensitivity and [&ge;]70% specificity. Compared to using the same thresholds for all participants, adjusting CAD thresholds by age and sex strata resulted in a 1 to 2% increase in sensitivity without affecting specificity. Implications of all the available evidenceTo obtain high sensitivity with CAD screening in high-prevalence settings, low score thresholds may be needed. However, countries with a high burden of TB often do not have sufficient resources to test all individuals above a low threshold. In such settings, adjusting CAD thresholds based on individual characteristics associated with TB prevalence (e.g., male sex) and those associated with false-positive X-ray results (e.g., old age) can potentially improve the efficiency of TB screening programs.

BackgroundCT-based radio-biomarkers could provide non-invasive insights into tumour biology to risk-stratify patients. One of the limitations is laborious manual segmentation of regions-of-interest (ROI). We present a deep learning auto-segmentation pipeline for radiomic analysis. Patients and Methods153 patients with resected stage 2A-3B non-small cell lung cancer (NSCLCs) had tumours segmented using nnU-Net with review by two clinicians. The nnU-Net was pretrained with anatomical priors in non-cancerous lungs and finetuned on NSCLCs. Three ROIs were segmented: intra-tumoural, peri-tumoural, and whole lung. 1967 features were extracted using PyRadiomics. Feature reproducibility was tested using segmentation perturbations. Features were selected using minimum-redundancy-maximum-relevance with Random Forest-recursive feature elimination nested in 500 bootstraps. ResultsAuto-segmentation time was [~]36 seconds/series. Mean volumetric and surface Dice-Sorensen coefficient (DSC) scores were 0.84 ({+/-}0.28), and 0.79 ({+/-}0.34) respectively. DSC were significantly correlated with tumour shape (sphericity, diameter) and location (worse with chest wall adherence), but not batch effects (e.g. contrast, reconstruction kernel). 6.5% cases had missed segmentations; 6.5% required major changes. Pre-training on anatomical priors resulted in better segmentations compared to training on tumour-labels alone (p<0.001) and tumour with anatomical labels (p<0.001). Most radiomic features were not reproducible following perturbations and resampling. Adding radiomic features, however, did not significantly improve the clinical model in predicting 2-year disease-free survival: AUCs 0.67 (95%CI 0.59-0.75) vs 0.63 (95%CI 0.54-0.71) respectively (p=0.28). ConclusionOur study demonstrates that integrating auto-segmentation into radio-biomarker discovery is feasible with high efficiency and accuracy. Whilst radiomic analysis show limited reproducibility, our auto-segmentation may allow more robust radio-biomarker analysis using deep learning features.

Background and purposeAccurate estimation of Overall Survival (OS) in Non-Small Cell Lung Cancer (NSCLC) patients provides critical insights for treatment planning. While previous studies showed that radiomics and Deep Learning (DL) features increased prediction accuracy, this study aimed to examine whether a model that combines the radiomics and DL features with the clinical and dosimetric features outperformed other models. Materials and methodsWe collected pre-treatment lung CT scans and clinical data for 225 NSCLC patients from the Maastro Clinic: 180 for training and 45 for testing. Radiomics features were extracted using the Python radiomics feature extractor, and DL features were obtained using a 3D ResNet model. An ensemble model comprising XGB and NN classifiers was developed using: (1) clinical features only; (2) clinical and radiomics features; (3) clinical and DL features; and (4) clinical, radiomics, and DL features. The performance metrics were evaluated for the test and K-fold cross-validation data sets. ResultsThe prediction model utilizing only clinical variables provided an Area Under the Receiver Operating Characteristic Curve (AUC) of 0.64 and a test accuracy of 77.55%. The best performance came from combining clinical, radiomics, and DL features (AUC: 0.84, accuracy: 85.71%). The prediction improvement of this model was statistically significant compared to models trained with clinical features alone or with a combination of clinical and radiomics features. ConclusionIntegrating radiomics and DL features with clinical characteristics improved the prediction of OS after radiotherapy for NSCLC patients. The increased accuracy of our integrated model enables personalized, risk-based treatment planning, guiding clinicians toward more effective interventions, improved patient outcomes and enhanced quality of life.

Artificial intelligence (AI) is rapidly transforming healthcare, but its benefits are not reaching all patients equally. Children remain overlooked with only 17% of FDA-approved medical AI devices labeled for pediatric use. In this work, we demonstrate that this exclusion may stem from a fundamental data gap. Our systematic review of 181 public medical imaging datasets reveals that children represent just under 1% of available data, while the majority of machine learning imaging conference papers we surveyed utilized publicly available data for methods development. Much like systematic biases of other kinds in model development, past studies have demonstrated the manner in which pediatric representation in data used for models intended for the pediatric population is essential for model performance in that population. We add to these findings, showing that adult-trained chest radiograph models exhibit significant age bias when applied to pediatric populations, with higher false positive rates in younger children. This work underscores the urgent need for increased pediatric representation in publicly accessible medical datasets. We provide actionable recommendations for researchers, policymakers, and data curators to address this age equity gap and ensure AI benefits patients of all ages. 1-2 sentence summaryOur analysis reveals a critical healthcare age disparity: children represent less than 1% of public medical imaging datasets. This gap in representation leads to biased predictions across medical image foundation models, with the youngest patients facing the highest risk of misdiagnosis.

A major global health and wellness issue causing major health problems and death, pneumonia underlines the need of quickly and precisely identifying and treating it. Though imaging technology has advanced, radiologists manual reading of chest X-rays still constitutes the basic method for pneumonia detection, which causes delays in both treatment and medical diagnosis. This study proposes a pneumonia detection method to automate the process using deep learning techniques. The concept employs a bespoke convolutional neural network (CNN) trained on different pneumonia-positive and pneumonia-negative cases from several healthcare providers. Various pre-processing steps were done on the chest radiographs to increase integrity and efficiency before teaching the design. Based on the comparison study with VGG19, ResNet50, InceptionV3, DenseNet201, and MobileNetV3, our bespoke CNN model was discovered to be the most efficient in balancing accuracy, recall, and parameter complexity. It shows 96.5% accuracy and 96.6% F1 score. This study contributes to the expansion of an automated, paired with a reliable, pneumonia finding system, which could improve personal outcomes and increase healthcare efficiency. The full project is available at here.

Combined Pulmonary Fibrosis and Emphysema (CPFE), formally recognized as a distinct pulmonary syndrome in 2022, is characterized by unique clinical features and pathogenesis that may lead to respiratory failure and death. However, the diagnosis of CPFE presents significant challenges that hinder effective treatment. Here, we assembled three-dimensional (3D) reconstruction data of the chest High-Resolution Computed Tomography (HRCT) of patients from multiple hospitals across different provinces in China, including Xiangya Hospital, West China Hospital, and Fujian Provincial Hospital. Using this dataset, we developed CPFENet, a deep learning-based diagnostic model for CPFE. It accurately differentiates CPFE from COPD, with performance comparable to that of professional radiologists. Additionally, we developed a CPFE score based on radiomic analysis of 3D CT images to quantify disease characteristics. Notably, female patients demonstrated significantly higher CPFE scores than males, suggesting potential sex-specific differences in CPFE. Overall, our study establishes the first diagnostic framework for CPFE, providing a diagnostic model and clinical indicators that enable accurate classification and characterization of the syndrome.

BackgroundLung ultrasound (LUS) offers advantages over traditional imaging for diagnosing pulmonary conditions, with superior accuracy compared to chest X-ray and similar performance to CT at lower cost. Despite these benefits, widespread adoption is limited by operator dependency, moderate interrater reliability, and training requirements. Deep learning (DL) could potentially address these challenges, but development of effective algorithms is hindered by the scarcity of comprehensive image repositories with proper metadata. MethodsWe created an open-source dataset of LUS images derived a multi-center study involving N=226 adult patients presenting with respiratory symptoms to emergency departments between March 2020 and April 2022. Images were acquired using a standardized scanning protocol (12-zone or modified 8-zone) with various point-of-care ultrasound devices. Three blinded researchers independently analyzed each image following consensus guidelines, with disagreements adjudicated to provide definitive interpretations. Videos were pre-processed to remove identifiers, and frames were extracted and resized to 128x128 pixels. ResultsThe dataset contains 1,874 video clips comprising 303,977 frames. Half of the participants (50%) had COVID-19 pneumonia. Among all clips, 66% contained no abnormalities, 18% contained B-lines, 4.5% contained consolidations, 6.4% contained both B-lines and consolidations, and 5.2% had indeterminate findings. Pathological findings varied significantly by lung zone, with anterior zones more frequently normal and less likely to show consolidations compared to lateral and posterior zones. DiscussionThis dataset represents one of the largest annotated LUS repositories to date, including both COVID-19 and non-COVID-19 patients. The comprehensive metadata and expert interpretations enhance its utility for DL applications. Despite limitations including potential device-specific characteristics and COVID-19 predominance, this repository provides a valuable resource for developing AI tools to improve LUS acquisition and interpretation.